CRL vs RVTY
Charles River Laboratories vs Revvity — AI-powered side-by-side comparison
CRL
Charles River Laboratories
61
Buy
VS
| Metric | CRL | RVTY |
|---|
| AI Score |
61
|
71
|
| Price |
$297.55
|
$124.78
|
| P/E Ratio |
-61.69×
|
58.57×
|
| ROE |
-4.6%
|
3.3%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
32.2%
|
52.1%
|
| Debt / Equity |
1.07×
|
0.46×
|
| Dividend Yield |
0.0%
|
0.2%
|
| RSI (14) |
79.8
|
67.0
|
| Beta |
1.376
|
1.072
|
| Expected Upside |
+1.4%
|
—
|
AI Committee View
Current Innellis committee reasoning for CRL versus RVTY.
RVTY leads by 10 points.
RVTY scores 71/100 (Buy) versus CRL at 61/100 (Buy).
CRL Committee View
80% agreement
5 analysts
The committee is genuinely divided. Growth Analyst sees a compelling case — 5 consecutive earnings beats -- consistent execution. Risk Analyst remains cautious — bollinger bandwidth of 35.8% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
Bear Case
- RSI at 80 is in overbought territory — Technical
- Weekly RSI at 87 -- overbought on the larger timeframe too — Technical
- Bollinger bandwidth of 35.8% signals elevated volatility — Risk
RVTY Committee View
100% agreement
4 analysts
The primary driver is 5 consecutive earnings beats -- consistent execution. The main limiting factor is sector concentration is already high (hhi 3068.56). The committee is constructive but not yet at full conviction.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
Bear Case
- Stochastic RSI (91.1) confirms overbought conditions.
- Bearish candlestick pattern(s) detected: Bearish Engulfing.